Immediate Impact
8 from Science/Nature 90 standout
Citing Papers
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
2022 Standout
Works of M Latteri being referenced
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study
2005
Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype
2002
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| M Latteri | 61 | 224 | 161 | 98 | 6 | 334 | |
| Toshitaka Tsuda | 91 | 178 | 59 | 115 | 11 | 347 | |
| N. Hayashi | 76 | 166 | 116 | 60 | 9 | 322 | |
| Liisa Chang | 42 | 175 | 82 | 101 | 5 | 318 | |
| Nhu Le | 92 | 128 | 98 | 172 | 7 | 367 | |
| Ulrika A. Hänninen | 45 | 156 | 127 | 61 | 10 | 324 | |
| M. Svrcek | 80 | 172 | 167 | 73 | 9 | 359 | |
| Burçin Baran | 88 | 243 | 134 | 85 | 7 | 342 | |
| Jennifer Biggs | 128 | 94 | 69 | 103 | 6 | 359 | |
| C.‐J. Hsieh | 91 | 164 | 100 | 34 | 9 | 368 | |
| Nicolas Cézé | 55 | 183 | 35 | 54 | 10 | 344 |
All Works
Loading papers...